Faeth Therapeutics grants new-hire inducement stock options for 180,350 shares

Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc.

FTH

0.00
  • Faeth Therapeutics issued stock options for 180,350 shares under its 2026 Inducement Plan for six newly hired employees.
  • 157,850 options granted June 25, 2026 at USD 24.67; 22,500 options granted June 29, 2026 at USD 23.22.
  • Options vest 25% on the first anniversary of each employee’s start date; remainder vests monthly over the next 36 months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faeth Therapeutics Inc published the original content used to generate this news brief via Business Wire (Ref. ID: 202607031600BIZWIRE_USPR_____20260703_BW384698) on July 03, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.